Evidence map›Paper›PMID 40671122›Full record

ArticleJournal of nanobiotechnology2025

Efficacy and safety of Fe-curcumin coordination polymer nanodots to prevent corneal neovascularization in alkali burn models.

Yan Huo, Lele Song, Zhihui Han, Yihan Yang, Tianyao Wang, Zhao Chen, Qi Yang, Yongkang Qiu, Wenpeng Huang, Ran Tao and 2 more

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yan Huo *Department of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str, Xicheng Dist, Beijing, 100034, China.
Lele Song *Department of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str, Xicheng Dist, Beijing, 100034, China.
Zhihui Han *Institute of Functional Nano & Soft Materials (FUNSOM), College of Nano Science & Technology (CNST), Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, Jiangsu, 215123, China.
Yihan YangDepartment of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str, Xicheng Dist, Beijing, 100034, China.
Tianyao WangDepartment of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str, Xicheng Dist, Beijing, 100034, China.
Zhao ChenDepartment of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str, Xicheng Dist, Beijing, 100034, China.
Qi YangDepartment of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str, Xicheng Dist, Beijing, 100034, China.
Yongkang QiuDepartment of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str, Xicheng Dist, Beijing, 100034, China.
Wenpeng HuangDepartment of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str, Xicheng Dist, Beijing, 100034, China.
Ran TaoDepartment of Plastic and Reconstructive Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China. lauruatr@163.com.
Liang ChengInstitute of Functional Nano & Soft Materials (FUNSOM), College of Nano Science & Technology (CNST), Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, Jiangsu, 215123, China. lcheng2@suda.edu.cn.
Lei KangDepartment of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str, Xicheng Dist, Beijing, 100034, China. kanglei@bjmu.edu.cn.

Funding

Beijing Municipal Science & Technology Commission Z221100007422027Beijing Nova Program 20240484725National High Level Hospital Clinical Research Funding 2023IR17National Key Research and Development Program of China 2024YFE0113500National Natural Science Foundation of China 82472018Noncommunicable Chronic Diseases-National Science and Technology Major Project 2023ZD0500900Scientific and Technological Achievements Transformation Incubation Guidance Fund Project of Peking University First Hospital 2024CX18
6 · The paper itself

Abstract

Alkali burns pose a significant risk of corneal injury, leading to potential blindness. During the progression of alkali burns, heightened oxidation levels can induce corneal damage, resulting in diminished clarity and vision loss. In this study, we chose metallic iron in conjunction with a small molecule, curcumin, to synthesize a curcumin-iron coordinated nanocomposite aimed at enhancing the bioaccessibility and targeting capabilities of curcumin. It could be found that Fe-curcumin coordination polymer nanodots (Fe-Cur CPNs) were comparably effective in suppressing corneal neovascularization, and they exhibited notable advantages in promoting corneal epithelial repair with minimal adverse effects. Additionally, Fe-Cur CPNs inhibited the activation of the nuclear factor-κ-gene binding (NF-κB) signaling pathway by scavenging reactive oxygen species (ROS), thus mitigating corneal neovascularization, which might represent a potential mechanism underlying the therapeutic effect of the Fe-Cur CPNs in alkali burn treatment. Moreover, treatment with the Fe-Cur CPNs did not result in any signs of cytotoxicity, hematological toxicity, or internal organ damage, further confirming the safety profile of this therapeutic agent. In conclusion, Fe-Cur CPNs present a novel, safe, and efficacious approach for addressing corneal alkali burns.

Indexed as

Burns, ChemicalCorneal NeovascularizationCurcuminEye BurnsIronPolymersAlkaliesAnimalsCorneaDisease Models, AnimalHumansMaleMiceNF-kappa BReactive Oxygen SpeciesAlkaliesCurcuminIronNF-kappa BPolymersReactive Oxygen SpeciesCorneal alkali burnFe-curcumin coordination polymer nanodots (Fe-Cur CPNs)NeovascularizationReactive oxygen speciesToxicity

Identifiers

PMID40671122
PMCPMC12265349

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.